The effect of lisuride hydrogen maleate, an ergot derivative on anterior pituitary hormone secretion in man (Q39703948)

14 September 2017

The effect of lisuride hydrogen maleate, an ergot derivative on anterior pituitary hormone secretion in man (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A117952

30 April 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A117952

30 April 2022

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1979.TB03041.X

30 April 2022

6

Besser GM

1 reference

14 September 2017

G. Delitala

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A117952

30 April 2022

J. A. Wass

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A117952

30 April 2022

W. A. Stubbs

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A117952

30 April 2022

A. Jones

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A117952

30 April 2022

S. Williams

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A117952

30 April 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=117952

30 April 2022

publication date

1 July 1979

1 reference

full work available at URL

14 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2265.1979.tb03041.x

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1979.TB03041.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2265.1979.tb03041.x/fullpdf

30 April 2022

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1979.TB03041.X

30 April 2022

published in

Clinical Endocrinology

1 reference

14 September 2017

11

1 reference

14 September 2017

1

1 reference

14 September 2017

1-9

1 reference

Treatment of parkinsonism with bromocriptine.

14 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1979.TB03041.X

Long-term treatment of parkinsonism with bromocriptine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1979.TB03041.X

Effect of ergot drugs on central catecholamine neurons: evidence for a stimulation of central dopamine neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1979.TB03041.X

Metoclopramide as a dopamine antagonist in the heart and gut of the mollusc Tapes watlingi.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1979.TB03041.X

Direct dopaminergic action of lisuride hydrogen maleate, an ergot derivative, in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1979.TB03041.X

Effect of lisuride and other ergot derivatives on monoaminergic mechanisms in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1979.TB03041.X

Effect of metoclopramide on turnover of brain dopamine noradrenaline and 5-hydroxytryptamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1979.TB03041.X

Evidence for dopaminergic control of thyrotrophin secretion in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1979.TB03041.X

Galactorrhoea: Successful Treatment with Reduction of Plasma Prolactin Levels by Brom-ergocryptine

21 January 2018

1

3

669

BESSER G.M.

1972

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1979.TB03041.X

Dopamine infusion acutely inhibits the TSH and prolactin response to TRH

30 April 2022

2

41

985

BESSES G.S.

1975

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1979.TB03041.X

Changes in Plasma Growth Hormone Levels in Normal and Acromegalic Subjects Following Administration of 2-Bromo-α-Ergocryptine

30 April 2022

5

40

363

CAMANNI F.

1975

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1979.TB03041.X

The inhibition of prolactin secretion in man by CB-154 (2-Br-alpha-ergocryptine).

30 April 2022

8

35

768

POZO E.

1972

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1979.TB03041.X

Effect of levodopa (L-DOPA) on human hypophyseal tropic hormone release

30 April 2022

10

33

709

EDDY R.L.

1971

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1979.TB03041.X

Prolactin Inhibiting Activity of Dopamine-Free Subcellular Fractions from Rat Mediobasal Hypothalamus

30 April 2022

11

24

147

ENJALBERT A.

1977

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1979.TB03041.X

Plasma Prolactin Activity in Inappropriate Lactation

30 April 2022

12

3

225

FORSYTH L.A.

1971

0 references

Effect of the Ergot Derivative Lisuride Hydrogen Maleate on Serum Prolactin Concentrations in Female Rats

13

98

598

GRAF K.J.

1976

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1979.TB03041.X

Effect of prolactin inhibitory agents on the ectopic anterior pituitary and the mammary gland in rats

30 April 2022

14

85

267

GRAF K.J.

1977

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1979.TB03041.X

On the Role of the Central Noradrenergic and Dopaminergic Systems in the Regulation of TSH Secretion in the Rat

30 April 2022

17

100

496

KRULICH L.

1977

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1979.TB03041.X

The Inhibitory Effect of Dopamine Agonists on LH Release in Women1

30 April 2022

18

44

728

LACHELIN G.E.L.

1977

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1979.TB03041.X

Effect of apomorphine on growth hormone, prolactin, luteinizing hormone and follicle-stimulating hormone levels in human serum

30 April 2022

19

37

719

LAL S.

1973

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1979.TB03041.X

Effects of dopamine infusion on pituitary hormone secretion in humans

30 April 2022

20

43

668

LEBLANC H.

1976

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1979.TB03041.X

Decreased plasma growth hormone (GH) levels in acromegalics following CB 154(2-Br-alpha ergocryptine) administration

30 April 2022

21

38

910

LIUZZI A.

1974

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1979.TB03041.X

Letter: Metaclopramide and prolactin

30 April 2022

24

2

729

McNEILLY AS.

1974

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1979.TB03041.X

Studies on pathogenesis and treatment in postmenopausal and senile osteoporosis

30 April 2022

25

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1979.TB03041.X

The Effect of Catecholamines on Hormone Release from Anterior Pituitaries and Ventral Hypothalami Incubated <i>in vitro</i>

30 April 2022

27

13

151

QUIJADA M.

1973

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1979.TB03041.X

The role of catecholamines in the release of anterior pituitary prolactin in vitro.

30 April 2022

29

95

1202

SHAAR C.J.

1974

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1979.TB03041.X

Serotoninergic control of rat growth hormone secretion

30 April 2022

30

17

245

SMYTHE G.A.

1975

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1979.TB03041.X

Long-term Treatment of Galactorrhoea and Hypogonadism with Bromocriptine

30 April 2022

34

2

419

THORNER M.O.

1974

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1979.TB03041.X

Bromocriptine treatment of acromegaly

30 April 2022

Effect of the Dopamine Agonist, Lergotrile Mesylate, on Circulating Anterior Pituitary Hormones in Man*

35

0 references

36

47

372

THORNER M.O.

1978

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1979.TB03041.X

Long-term treatment of acromegaly with bromocriptine

30 April 2022

38

1

875

WASS J.A.H.

1977

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1979.TB03041.X

30 April 2022

Identifiers

1 reference

14 September 2017

1 reference